Senate and House Lawmakers Unveil Competing 340B Reform Proposals By Abdie Santiago —

https://www.thefdalawblog.com/2026/07/senate-and-house-lawmakers-unveil-competing-340b-reform-proposals/?utm_source=rss&utm_medium=rss&utm_campaign=senate-and-house-lawmakers-unveil-competing-340b-reform-proposals For years, debates over the 340B Drug Pricing Program have played out primarily through litigation, agency guidance, and stakeholder advocacy. Congress, by contrast, has largely remained on the sidelines. That may be changing. Within two weeks, lawmakers in both chambers released significant reform proposals that would address some of the program’s most disputed issues, including patient eligibility, contract pharmacies, transparency requirements, and pricing mechanisms.